APA (7th ed.) Citation

Heller, M., Henrici, C., Büttner, J., Leube, S., Treske, I., Pospischil, P., . . . Sarrazin, C. (2023, April). SARS-CoV-2 neutralizing antibody therapies: An early retrospective cohort study of 26 hospitalized patients treated with bamlanivimab or casirivimab/imdevimab. International Journal of Infectious Diseases.

Chicago Style (17th ed.) Citation

Heller, Martin, et al. "SARS-CoV-2 Neutralizing Antibody Therapies: An Early Retrospective Cohort Study of 26 Hospitalized Patients Treated with Bamlanivimab or Casirivimab/imdevimab." International Journal of Infectious Diseases Apr. 2023.

MLA (9th ed.) Citation

Heller, Martin, et al. "SARS-CoV-2 Neutralizing Antibody Therapies: An Early Retrospective Cohort Study of 26 Hospitalized Patients Treated with Bamlanivimab or Casirivimab/imdevimab." International Journal of Infectious Diseases, Apr. 2023.